GE HealthCare Technologies Inc.

Equities

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
76.34 ^USD	-0.86%		-2.13%	-1.27%

Jun. 05	Transcript : GE HealthCare Technologies Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:00 AM
Jun. 05	Nucleus RadioPharma, Inc. announced that it has received $66.099956 million in funding from a group of investors	CI

GE Healthcare Technologies Inc. Announces Resignation of Betty D. Larson as Chief People Officer

February 05, 2024 at 09:21 am EST

On January 31, 2024, Betty D. Larson, Chief People Officer, notified GE HealthCare Technologies Inc. that she will be resigning from her role at the Company and that her last day at the Company will be March 21, 2024.

Latest news about GE HealthCare Technologies Inc.

Transcript : GE HealthCare Technologies Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:00 AM	Jun. 05
Nucleus RadioPharma, Inc. announced that it has received $66.099956 million in funding from a group of investors	Jun. 04	CI
GE HealthCare, Tampa General Hospital Expand Collaboration in Imaging, Ultrasound Technology	May. 30	MT
GE Healthcare and Tampa General Hospital Expand Long-Term Partnership to Benefit Patients and Clinicians Across the State of Florida	May. 30	CI
Goldman Sachs Initiates GE HealthCare Technologies With Neutral Rating, $87 Price Target	May. 30	MT
GE Healthcare Names Adam Holton as Chief People Officer	May. 29	CI
Some of the biggest splits in Corporate America	May. 23	RE
GE HealthCare Technologies Insider Sold Shares Worth $7,109,427, According to a Recent SEC Filing	May. 16	MT
Transcript : GE HealthCare Technologies Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:00 AM	May. 14
GE Healthcare and Medis Medical Imaging Announces Collaboration Focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease	May. 14	CI
GE HealthCare Unveils SIGNA MAGNUS, an FDA 510(K) Pending Head-Only Magnetic Resonance (MR) Scanner Designed to Explore Advance Advancements in Neuro Science	May. 05	CI
Mizuho Adjusts Price Target on GE HealthCare Technologies to $105 From $110	May. 01	MT
GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress	May. 01	CI
Jefferies Adjusts Price Target on GE HealthCare Technologies to $87 From $92	May. 01	MT
Health Care Flat Amid Mixed Earnings -- Health Care Roundup	Apr. 30	DJ
Equity Markets Slide Ahead of Fed Rate Decision	Apr. 30	MT
Equity Markets Drop Ahead of Fed Rate Decision	Apr. 30	MT
Sector Update: Health Care Stocks Mixed Late Afternoon	Apr. 30	MT
Equity Markets Down Ahead of Amazon Earnings	Apr. 30	MT
Top Midday Decliners	Apr. 30	MT
Wells Fargo Cuts GE HealthCare Technologies' Price Target to $88 From $90	Apr. 30	MT
Piper Sandler Adjusts GE HealthCare Technologies' Price Target to $92 From $94	Apr. 30	MT
Equity Markets Fall Intraday as Traders Parse Earnings, Await Amazon Results	Apr. 30	MT
Sector Update: Health Care Stocks Gain in Afternoon Trading	Apr. 30	MT
Wall Street stocks fall as markets weigh strong wage data, Fed meeting	Apr. 30	RE

Chart GE HealthCare Technologies Inc.

Duration

Period

More charts

Company Profile

GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-22 - Q2 2024 Earnings Release (Projected)

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for GE HealthCare Technologies Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

77 USD

Average target price

92.74 USD

Spread / Average Target

+20.44%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
GE HEALTHCARE TECHNOLOGIES INC.	-1.27%	35.15B
THERMO FISHER SCIENTIFIC	+9.48%	221B
DANAHER CORPORATION	+13.72%	198B
INTUITIVE SURGICAL, INC.	+23.79%	148B
BOSTON SCIENTIFIC CORPORATION	+33.39%	112B
SIEMENS HEALTHINEERS AG	+4.75%	66.85B
EDWARDS LIFESCIENCES CORPORATION	+15.59%	52.84B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.16%	50.86B
AGILENT TECHNOLOGIES, INC.	-4.35%	38.75B
RESMED, INC.	+22.61%	31.07B

Other Advanced Medical Equipment & Technology